The last decade has witnessed important advances in the field of managing cancer during
pregnancy. However, still limited data is available on the safety of administering targeted …

Simple Summary The use of anti-cancer treatments in pregnant women is an increasingly
common situation given the increasing age at first pregnancy. The aim of this study is to …

Objective Lung cancer is an uncommon diagnosis during pregnancy. The combination of
smoking in young women, increased maternal age during pregnancy, and increasing …

Introduction Lung cancer associated with pregnancy is rare but on the increase. The use of
tyrosine kinase inhibitor (TKI) therapy for advanced oncogenic-driven non-small cell lung …

Lung cancer is a major cause of mortality and morbidity in Malaysia and worldwide. This
paper reviews all research and publications on lung cancer in Malaysia published between …

Background There is no standard procedure available to diagnose and treat with pregnancy-
associated non-small cell lung cancer (NSCLC). The present study was to investigate the …

Introduction Alterations in the highly-actionable lung cancer oncogenes, EGFR, ALK and
ROS1, occur across the age spectrum. Pregnancy and plans for motherhood consequently …

Background The use of tyrosine kinase inhibitors (TKi s) during pregnancy in humans
remains rare, and little data are available on their transplacental passage. Erlotinib and …

Although cancer diagnoses during pregnancy are rare, they have been increasing with the
rise in maternal age and are now a topic of international concern. In some cases, the …

The incidence of lung cancer is rising in pregnancy, which is diagnosed on stage III–IV in
98%. Almost half of these patients are non-smokers, who are associated with more …